Blue Clay Capital Management, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.

Quarter-by-quarter ownership
Blue Clay Capital Management, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$1,748,000
-9.1%
17,125
+6.2%
1.97%
-11.9%
Q2 2016$1,923,000
+1.9%
16,125
-8.5%
2.24%
+25.6%
Q1 2016$1,887,000
-13.7%
17,625
-12.6%
1.78%
-1.8%
Q4 2015$2,187,000
+15.2%
20,175
-9.0%
1.81%
+19.8%
Q3 2015$1,899,000
-26.7%
22,175
-13.6%
1.51%
+3.1%
Q2 2015$2,591,000
-8.4%
25,675
-30.0%
1.47%
-0.5%
Q1 2015$2,828,000
+27.7%
36,675
-11.8%
1.48%
-8.8%
Q4 2014$2,214,00041,6001.62%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders